• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 4
  • 4
  • 3
  • 2

PRICE

7
8
10
13

PUBLISHED

0
1
1
13

PRODUCT TYPE

7
6

Search "Micromet Inc-Therapeutic Competitors" returned 13 results.

PRODUCT TITLE
Micromet, Inc. (MITI) - Financial and Strategic SWOT Analysis Review Micromet, Inc. (MITI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Micromet, Inc. (MITI) - Financial and Strategic SWOT Analysis Review

Micromet, Inc. (MITI) - Financial and Strategic SWOT Analysis Review Summary Micromet, Inc. (Micromet) is a biopharmaceutical company engaged in the development of novel antibody-based therapeutic...

September 2011
FROM
Micromet, Inc.: SWOT Analysis & Company Profile Micromet, Inc.: SWOT Analysis & Company Profile - Product Thumbnail Image

Micromet, Inc.: SWOT Analysis & Company Profile

Synopsis Business Review’s Micromet, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company...

February 2010
FROM
Competitor Analysis: Her2 and Her3 Receptor Antagonists Competitor Analysis: Her2 and Her3 Receptor Antagonists - Product Thumbnail Image

Competitor Analysis: Her2 and Her3 Receptor Antagonists

The present Competitive Intelligence Report about Her2 and Her3 receptor antagonists provides a competitor evaluation in the field of Her2 (ErbB2) and Her3 receptor targeting molecules for treatment...

September 2011
FROM
Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases - Product Thumbnail Image

Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases

The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed...

December 2010
FROM
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion

The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the global top 20 best-selling drugs...

January 2013
FROM
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

March 2011
FROM
Bayer Schering Pharma AG (SHRGY) - Strategic Analysis Review Bayer Schering Pharma AG (SHRGY) - Strategic Analysis Review - Product Thumbnail Image

Bayer Schering Pharma AG (SHRGY) - Strategic Analysis Review

Bayer Schering Pharma AG (Bayer Schering) is a global pharmaceutical company, engaged in the development, manufacturing and selling of pharmaceutical products. It is also involved in the research for...

September 2010
FROM
Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review

Tamir Biotechnology, Inc. (ACEL) - Financial and Strategic SWOT Analysis Review Summary Tamir Biotechnology, Inc. (formerly known as Alfacell Corporation) is a biopharmaceutical company engaged in...

September 2011
FROM

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

March 2015
FROM
Seattle Genetics, Inc. (SGEN) - Financial and Strategic Analysis Review Seattle Genetics, Inc. (SGEN) - Financial and Strategic Analysis Review - Product Thumbnail Image

Seattle Genetics, Inc. (SGEN) - Financial and Strategic Analysis Review

Seattle Genetics, Inc. (Seattle) is a biotechnology company engaged in the discovery and the development of monoclonal antibody-based drugs to treat cancer and autoimmune diseases. The company's lead...

August 2010
FROM
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

“Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how Pharmaceutical industry...

March 2012
FROM
Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

“Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry” is a new report by ICD Research that analyzes how Pharmaceutical...

March 2012
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG